Literature DB >> 16864817

Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Marcelo E Bigal1, Richard B Lipton.   

Abstract

OBJECTIVE: To assess the influence of the body mass index (BMI) on the prevalence and severity of chronic daily headache (CDH) and its most frequent subtypes, transformed migraine (TM) and chronic tension-type headache (CTTH).
METHODS: The authors gathered information on headache, medical features, height, and weight using a computer-assisted telephone interview. Participants were divided into five categories, based on BMI: underweight (<18.5), normal weight (18.5 to 24.9), overweight (25 to 29.9), obese (30 to 34.9), and morbidly obese (>35). The prevalence and severity of CDH, TM, and CTTH were assessed. Multivariate analyses modeling these diagnoses as a function of BMI were conducted.
RESULTS: Among 30,215 participants, the prevalence of CDH was 4.1%; 1.3% had TM and 2.8% CTTH. In contrast with the normal weight group (3.9%), the prevalence of CDH was higher in obese (5.0% [odds ratio (OR) = 1.3, 95% CI = 1.1-1.6]) and morbidly obese (6.8% [OR = 1.8, 95% CI = 1.4 to 2.2]). BMI had a strong influence on the prevalence of TM, which ranged from 0.9% of the normal weighted to 1.2% of the overweight (OR = 1.4 [1.1 to 1.8]), 1.6% of the obese (OR = 1.7 [1.2 to 2.43]), and 2.5% of the morbidly obese (OR = 2.2 [1.5 to 3.2]). The effects of the BMI on the prevalence of CTTH were just significant in the morbidly obese group. Adjusted analyses showed that obesity was associated with CDH and TM but not CTTH.
CONCLUSIONS: Chronic daily headache and obesity are associated. Obesity is a stronger risk factor for transformed migraine than for chronic tension-type headache.

Entities:  

Mesh:

Year:  2006        PMID: 16864817     DOI: 10.1212/01.wnl.0000225052.35019.f9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  88 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

2.  The association of obesity with episodic and chronic migraine.

Authors:  Randolph W Evans; Michelle A Williams; Alan M Rapoport; B Lee Peterlin
Journal:  Headache       Date:  2012-03-08       Impact factor: 5.887

3.  Chronic daily headache, medication overuse, and obesity in children and adolescents.

Authors:  Ann Pakalnis; Donna Kring
Journal:  J Child Neurol       Date:  2011-09-27       Impact factor: 1.987

Review 4.  Migraine and metabolism.

Authors:  G Casucci; V Villani; D Cologno; F D'Onofrio
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

Review 5.  Sinus venous stenosis, intracranial hypertension and progression of primary headaches.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Pasquale Persico; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

6.  Higher augmentation index is associated with tension-type headache and migraine in middle-aged/older humans with obesity.

Authors:  Graziela Z Kalil; Ana Recober; Ann Hoang-Tienor; Miriam Bridget Zimmerman; William G Haynes; Gary L Pierce
Journal:  Obesity (Silver Spring)       Date:  2016-02-05       Impact factor: 5.002

Review 7.  [Exercise in migraine treatment. Review and discussion of clinical trials and implications for further trials].

Authors:  V Busch; C Gaul
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

8.  Body mass index, migraine, migraine frequency and migraine features in women.

Authors:  A C Winter; K Berger; J E Buring; T Kurth
Journal:  Cephalalgia       Date:  2009-02       Impact factor: 6.292

Review 9.  Functional imaging in chronic migraine.

Authors:  Farooq H Maniyar; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2013-05

10.  Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial.

Authors:  Dale S Bond; Kevin C O'Leary; J Graham Thomas; Richard B Lipton; George D Papandonatos; Julie Roth; Lucille Rathier; Richard Daniello; Rena R Wing
Journal:  Contemp Clin Trials       Date:  2013-03-22       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.